Medicure Inc. (MPH.V)
CAD 0.9
(0.0%)
CAD 0.9
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.9 Million CAD | -9.97% |
| 2022 | 3.22 Million CAD | -3.24% |
| 2021 | 3.32 Million CAD | -35.22% |
| 2020 | 5.13 Million CAD | -18.79% |
| 2019 | 6.32 Million CAD | 49.27% |
| 2018 | 4.23 Million CAD | 37.86% |
| 2017 | 3.07 Million CAD | -74.75% |
| 2016 | 12.17 Million CAD | 431.9% |
| 2015 | 2.28 Million CAD | 108.2% |
| 2014 | 1.09 Million CAD | 0.0% |
| 2012 | 902.79 Thousand CAD | 66.47% |
| 2011 | 542.32 Thousand CAD | 17.67% |
| 2010 | 460.88 Thousand CAD | -16.35% |
| 2009 | 550.97 Thousand CAD | -12.72% |
| 2008 | 631.3 Thousand CAD | 99.55% |
| 2007 | 316.35 Thousand CAD | -50.57% |
| 2006 | 640 Thousand CAD | 143.61% |
| 2005 | 262.71 Thousand CAD | -34.02% |
| 2004 | 398.2 Thousand CAD | -56.26% |
| 2003 | 910.33 Thousand CAD | 1553.69% |
| 2002 | 55.04 Thousand CAD | -38.75% |
| 2001 | 89.87 Thousand CAD | 0.0% |
| 2000 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.32 Million CAD | 14.55% |
| 2024 Q2 | 3.81 Million CAD | 14.87% |
| 2023 Q4 | 2.9 Million CAD | -14.12% |
| 2023 Q2 | 3.25 Million CAD | 17.36% |
| 2023 FY | 2.9 Million CAD | -9.97% |
| 2023 Q3 | 3.37 Million CAD | 3.65% |
| 2023 Q1 | 2.77 Million CAD | -13.82% |
| 2022 Q3 | 3.66 Million CAD | 17.08% |
| 2022 Q4 | 3.22 Million CAD | -11.99% |
| 2022 FY | 3.22 Million CAD | -3.24% |
| 2022 Q1 | 3.45 Million CAD | 3.75% |
| 2022 Q2 | 3.12 Million CAD | -9.5% |
| 2021 Q3 | 3.94 Million CAD | -14.03% |
| 2021 Q1 | 4.83 Million CAD | -5.88% |
| 2021 Q4 | 3.32 Million CAD | -15.66% |
| 2021 FY | 3.32 Million CAD | -35.22% |
| 2021 Q2 | 4.59 Million CAD | -5.09% |
| 2020 Q2 | 7.1 Million CAD | -11.36% |
| 2020 FY | 5.13 Million CAD | -18.79% |
| 2020 Q3 | 6.2 Million CAD | -12.76% |
| 2020 Q1 | 8.02 Million CAD | 26.74% |
| 2020 Q4 | 5.13 Million CAD | -17.14% |
| 2019 FY | 6.32 Million CAD | 49.27% |
| 2019 Q2 | 4.91 Million CAD | 14.88% |
| 2019 Q3 | 8.27 Million CAD | 68.42% |
| 2019 Q1 | 4.27 Million CAD | 0.84% |
| 2019 Q4 | 6.32 Million CAD | -23.49% |
| 2018 Q1 | 2.55 Million CAD | -16.85% |
| 2018 FY | 4.23 Million CAD | 37.86% |
| 2018 Q4 | 4.23 Million CAD | -2.21% |
| 2018 Q3 | 4.33 Million CAD | 40.91% |
| 2018 Q2 | 3.07 Million CAD | 20.33% |
| 2017 FY | 3.07 Million CAD | -74.75% |
| 2017 Q4 | 3.07 Million CAD | 14.92% |
| 2017 Q3 | 2.67 Million CAD | -78.38% |
| 2017 Q2 | 12.37 Million CAD | -1.44% |
| 2017 Q1 | 12.55 Million CAD | 3.14% |
| 2016 FY | 12.17 Million CAD | 431.9% |
| 2016 Q2 | 3.29 Million CAD | 32.17% |
| 2016 Q1 | 2.48 Million CAD | 8.75% |
| 2016 Q3 | 3.53 Million CAD | 7.57% |
| 2016 Q4 | 12.17 Million CAD | 244.02% |
| 2015 Q4 | 2.28 Million CAD | 110.36% |
| 2015 Q1 | 1.2 Million CAD | 0.0% |
| 2015 Q3 | 1.08 Million CAD | 39.01% |
| 2015 FY | 2.28 Million CAD | 108.2% |
| 2015 Q2 | 782.85 Thousand CAD | -34.97% |
| 2014 FY | 1.09 Million CAD | 0.0% |
| 2014 Q1 | 738.94 Thousand CAD | -9.95% |
| 2014 Q2 | 765.65 Thousand CAD | 3.61% |
| 2014 Q3 | 630.11 Thousand CAD | -17.7% |
| 2013 Q1 | 933.95 Thousand CAD | 18.04% |
| 2013 Q2 | 902.79 Thousand CAD | -3.34% |
| 2013 Q3 | 887.89 Thousand CAD | -1.65% |
| 2013 Q4 | 820.57 Thousand CAD | -7.58% |
| 2012 Q2 | 542.32 Thousand CAD | -17.13% |
| 2012 FY | 902.79 Thousand CAD | 66.47% |
| 2012 Q4 | 791.19 Thousand CAD | 56.9% |
| 2012 Q3 | 504.25 Thousand CAD | -7.02% |
| 2012 Q1 | 654.4 Thousand CAD | 16.42% |
| 2011 FY | 542.32 Thousand CAD | 17.67% |
| 2011 Q4 | 562.1 Thousand CAD | 0.15% |
| 2011 Q3 | 561.27 Thousand CAD | 21.78% |
| 2011 Q2 | 460.88 Thousand CAD | 22.55% |
| 2011 Q1 | 376.08 Thousand CAD | -20.99% |
| 2010 Q1 | 634.39 Thousand CAD | -22.49% |
| 2010 Q2 | 550.97 Thousand CAD | -13.15% |
| 2010 Q3 | 512.38 Thousand CAD | -7.0% |
| 2010 Q4 | 475.97 Thousand CAD | -7.11% |
| 2010 FY | 460.88 Thousand CAD | -16.35% |
| 2009 Q1 | 617.05 Thousand CAD | -10.64% |
| 2009 Q3 | 581 Thousand CAD | -7.97% |
| 2009 Q2 | 631.3 Thousand CAD | 2.31% |
| 2009 Q4 | 818.43 Thousand CAD | 40.87% |
| 2009 FY | 550.97 Thousand CAD | -12.72% |
| 2008 Q4 | 690.51 Thousand CAD | -9.48% |
| 2008 Q3 | 762.83 Thousand CAD | 141.13% |
| 2008 Q2 | 316.35 Thousand CAD | 140.2% |
| 2008 Q1 | 131.7 Thousand CAD | -19.92% |
| 2008 FY | 631.3 Thousand CAD | 99.55% |
| 2007 Q3 | 602.84 Thousand CAD | -5.81% |
| 2007 Q1 | 705.99 Thousand CAD | -11.02% |
| 2007 FY | 316.35 Thousand CAD | -50.57% |
| 2007 Q4 | 164.47 Thousand CAD | -72.72% |
| 2007 Q2 | 640 Thousand CAD | -9.35% |
| 2006 Q1 | 221.96 Thousand CAD | -11.62% |
| 2006 Q4 | 793.46 Thousand CAD | -5.74% |
| 2006 Q2 | 262.71 Thousand CAD | 18.36% |
| 2006 FY | 640 Thousand CAD | 143.61% |
| 2006 Q3 | 841.73 Thousand CAD | 220.4% |
| 2005 FY | 262.71 Thousand CAD | -34.02% |
| 2005 Q3 | 148.93 Thousand CAD | -62.6% |
| 2005 Q1 | 747.61 Thousand CAD | -29.15% |
| 2005 Q2 | 398.2 Thousand CAD | -46.74% |
| 2005 Q4 | 251.14 Thousand CAD | 68.62% |
| 2004 Q3 | 1.83 Million CAD | 101.94% |
| 2004 Q2 | 910.33 Thousand CAD | 12.57% |
| 2004 FY | 398.2 Thousand CAD | -56.26% |
| 2004 Q1 | 808.7 Thousand CAD | 2712.2% |
| 2004 Q4 | 1.05 Million CAD | -42.6% |
| 2003 Q2 | 55.04 Thousand CAD | -30.97% |
| 2003 Q1 | 79.74 Thousand CAD | 139.81% |
| 2003 FY | 910.33 Thousand CAD | 1553.69% |
| 2003 Q3 | 52.35 Thousand CAD | -4.9% |
| 2003 Q4 | 28.75 Thousand CAD | -45.07% |
| 2002 FY | 55.04 Thousand CAD | -38.75% |
| 2002 Q4 | 33.25 Thousand CAD | -51.78% |
| 2002 Q3 | 68.96 Thousand CAD | 0.0% |
| 2001 FY | 89.87 Thousand CAD | 0.0% |
| 2000 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 123.74 Thousand CAD | -2243.51% |
| CanadaBis Capital Inc. | 5.82 Million CAD | 50.241% |
| Decibel Cannabis Company Inc. | 48.7 Million CAD | 94.046% |
| Delivra Health Brands Inc. | 1.47 Million CAD | -96.211% |
| Entourage Health Corp. | 10.01 Million CAD | 71.03% |
| Lifeist Wellness Inc. | 4.51 Million CAD | 35.715% |
| Cannara Biotech Inc. | 33.77 Million CAD | 91.413% |
| PharmaCielo Ltd. | 2.31 Million CAD | -25.48% |
| Rubicon Organics Inc. | 11.27 Million CAD | 74.289% |
| BioSyent Inc. | 5.89 Million CAD | 50.802% |
| Voyageur Pharmaceuticals Ltd. | 10.32 Thousand CAD | -27992.609% |